Webinar – Non-viral Cell Engineering with Stanford University, Touchlight, and MaxCyte: Advantages and Applications
In this virtual seminar, cell engineering scientists from Stanford University, Touchlight Genetics, and MaxCyte share promising advances in non-viral gene therapy. Join these experts from across the globe and learn about the latest innovations in gene delivery platforms and single-stranded CRISPR HDR donor technologies.
Key case studies will presented by Dr. Hyatt Want at Stanford University (Crystal Mackall & Steve Feldman Labs), Dr. Elena Stoyanova at Touchlight Genetics, and Dr. Marianna Romito at MaxCyte.
Each presenter will share data on how to increase engineering efficiency in primary and stem cells, all while maintaining high cell viability and recovery for applications in gene editing and autologous/allogeneic cell therapy.
Access the webinar here